Company news

NeuroOne Medical Technologies Corporation news in 2024

NeuroOne Medical Technologies Corporation's news releases, calls and decks from 2024, newest first.

View company

NeuroOne® Product Revenue Increases 77% to $3.5 Million in Fiscal 2024: Expects Product Revenue to Increase at Least 132% to at Least $8 Million in Fiscal 2025

December 16, 2024

NeuroOne® to Report Fourth Quarter and Fiscal Year 2024 Financial Results on December 17 at 9: 00 a.m. Eastern Time

December 3, 2024

NeuroOne Medical Technologies Corporation to Present at November 21st Virtual Investor Summit Microcap Event

November 12, 2024

NeuroOne® Announces Expansion of Existing Distribution Agreement with Zimmer Biomet for Commercialization of OneRF™ Ablation System

October 30, 2024

NeuroOne® Medical Technologies to Present at the 2024 ThinkEquity Conference

October 23, 2024

NeuroOne® Spinal Cord Stimulation Electrode Technology to be Featured at The Business of Pain Conference

September 23, 2024

NeuroOne® Announces Breakthrough Case Completed with OneRF™ Ablation System at the University Hospitals in Cleveland

September 9, 2024

NeuroOne® to Present at the H.C. Wainwright 26th Annual Global Investment Conference

September 4, 2024

NeuroOne® Reports Third Quarter Fiscal Year 2024 Financial Results and Provides Corporate Update

August 13, 2024

NeuroOne® to Report Third Quarter Fiscal Year 2024 Financial Results and Provide Corporate Update on August 14

August 11, 2024

NeuroOne® Announces $2.65 Million Equity Financing And $3.0 Million Credit Facility

August 4, 2024

NeuroOne® Announces First in Human Ablations Completed with OneRF™ Ablation System

June 24, 2024

NeuroOne® Granted Approval of ICD-10 Procedure Code for sEEG RF Ablation

June 19, 2024

NeuroOne® Reports Second Quarter Fiscal Year 2024 Financial Results and Provides Corporate Update

May 13, 2024

NeuroOne® to Report Second Quarter Fiscal Year 2024 Financial Results and Provide Corporate Update on May 14

May 9, 2024

NeuroOne® CEO Dave Rosa Featured on Bloomberg Technology

April 9, 2024

NeuroOne® Announces First Implant of OneRF™ Ablation Electrodes

April 8, 2024

NeuroOne® CEO Dave Rosa Featured on Fox Business Network’s Varney & Co.

April 3, 2024

NeuroOnes’s Innovative Electrode Brain Monitoring Seeks To Provide Insights Into Neurological Disorders

March 27, 2024

NeuroOne® Initiates Limited Commercial Launch of OneRF™ Ablation System

March 25, 2024

NeuroOne® to Participate in the 36th Annual Roth Conference

March 7, 2024

NeuroOne Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

February 22, 2024

NeuroOne® Reports First Quarter Fiscal Year 2024 Financial Results and Provides Corporate Update

February 12, 2024

NeuroOne® to Report First Quarter Fiscal Year 2024 Financial Results and Provide Corporate Update on February 13

February 7, 2024

Calls in 2024

Decks in 2024